Bath & Body Works’ (BBWI) “Outperform” Rating Reaffirmed at Telsey Advisory Group

Bath & Body Works (NYSE:BBWI)‘s stock had its “outperform” rating reissued by investment analysts at Telsey Advisory Group in a research report issued on Thursday, Marketbeat reports. They presently have a $38.00 price target on the stock, down from their previous price target of $43.00. Telsey Advisory Group’s price objective indicates a potential upside of 32.98% from the company’s previous close.

Several other equities analysts have also issued reports on BBWI. UBS Group boosted their target price on shares of Bath & Body Works from $32.00 to $36.00 and gave the company a “neutral” rating in a report on Tuesday, May 20th. Morgan Stanley dropped their price objective on Bath & Body Works from $49.00 to $43.00 and set an “overweight” rating on the stock in a research note on Tuesday, May 6th. Citigroup upped their target price on Bath & Body Works from $36.00 to $42.00 and gave the company a “buy” rating in a research report on Tuesday, May 20th. Cowen reaffirmed a “buy” rating on shares of Bath & Body Works in a research note on Thursday, February 27th. Finally, The Goldman Sachs Group dropped their price target on Bath & Body Works from $49.00 to $42.00 and set a “buy” rating on the stock in a research note on Tuesday, April 22nd. Four analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat.com, Bath & Body Works currently has an average rating of “Moderate Buy” and an average price target of $42.56.

Bath & Body Works Price Performance

Shares of BBWI stock opened at $28.58 on Thursday. The stock has a market capitalization of $6.09 billion, a PE ratio of 6.97, a PEG ratio of 0.92 and a beta of 1.87. The business’s 50 day simple moving average is $30.15 and its 200 day simple moving average is $33.96. Bath & Body Works has a one year low of $24.96 and a one year high of $52.99.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Thursday, May 29th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.47 by $0.02. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.42 billion. During the same quarter in the previous year, the company earned $0.38 EPS. The company’s revenue for the quarter was up 2.9% on a year-over-year basis. As a group, research analysts expect that Bath & Body Works will post 3.3 earnings per share for the current year.

Bath & Body Works announced that its board has initiated a stock repurchase plan on Thursday, February 27th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the company to reacquire up to 6.4% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s management believes its stock is undervalued.

Institutional Trading of Bath & Body Works

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. SRS Capital Advisors Inc. lifted its stake in shares of Bath & Body Works by 99.7% in the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock valued at $26,000 after buying an additional 329 shares in the last quarter. Golden State Wealth Management LLC bought a new position in Bath & Body Works in the 4th quarter valued at about $26,000. Lindbrook Capital LLC boosted its stake in Bath & Body Works by 81.9% during the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock valued at $37,000 after purchasing an additional 431 shares during the last quarter. Smartleaf Asset Management LLC boosted its stake in Bath & Body Works by 135.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,013 shares of the company’s stock valued at $39,000 after purchasing an additional 582 shares during the last quarter. Finally, SVB Wealth LLC bought a new stake in Bath & Body Works during the 1st quarter worth approximately $35,000. Institutional investors own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.